EUVIMEDEUVIMED entdecken
Crossref

How does colchicine use affect neutrophil/lymphocyte, monocyte/lymphocyte, and platelet/lymphocyte ratios in coronary artery disease?

Fatih Öztürk, Mehmet Yaman

Dicle Tıp Dergisi · 05.06.2026 · 53 (2) · 431-441

DOI: 10.5798/dicletip.1964621 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Dicle Tıp Dergisi, online erschienen am 05.06.2026. Verfasst von Fatih Öztürk und 1 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

It is an established medical fact that the reduction of inflammation plays a pivotal role in the development of atherosclerosis. This reduction of inflammation is an accepted treatment strategy for coronary artery disease (CAD). The objective of the present study was to demonstrate the effect of colchicine, a commonly used anti-inflammatory agent, on inflammatory markers.

Method

The study comprised a sample of 122 patients diagnosed with CAD, whose medical records were meticulously reviewed. Ratios of neutrophil/lymphocyte, monocyte/lymphocyte, and platelet/lymphocyte were calculated and recorded. Following a period of six months during which colchicine was administered, a recalculation of the values was performed.

Results

Prior to the commencement of treatment, the neutrophil/lymphocyte ratio (NLR) (3.99 ± 4.72), monocyte/lymphocyte ratio (MLR) (0.41 ± 0.42), and platelet/lymphocyte ratio (PLR) (129.6 ± 74.1) were observed. Following treatment, a decrease was observed in the neutrophil-to-lymphocyte ratio (NLR) (3.5 ± 3), MLR (0.38 ± 0.28), and PLR (122.6 ± 65). In the post-treatment period, statistically significant decreases were observed NLR, MLR, and PLR compared to pre-treatment levels (p

Zitieren

APA

Öztürk, F., & Yaman, M. (2026). How does colchicine use affect neutrophil/lymphocyte, monocyte/lymphocyte, and platelet/lymphocyte ratios in coronary artery disease?. Dicle Tıp Dergisi, 53(2), 431-441. https://doi.org/10.5798/dicletip.1964621

Vancouver

Öztürk F, Yaman M. How does colchicine use affect neutrophil/lymphocyte, monocyte/lymphocyte, and platelet/lymphocyte ratios in coronary artery disease?. Dicle Tıp Dergisi. 2026;53(2):431-441. doi:10.5798/dicletip.1964621

BibTeX
@article{ztrk2026,
  author = {Öztürk, Fatih and Yaman, Mehmet},
  title = {How does colchicine use affect neutrophil/lymphocyte, monocyte/lymphocyte, and platelet/lymphocyte ratios in coronary artery disease?},
  journal = {Dicle Tıp Dergisi},
  year = {2026},
  volume = {53},
  number = {2},
  pages = {431--441},
  doi = {10.5798/dicletip.1964621}
}
Kostenlos starten →